Advertisement
dr. pramod dhembare

Dr. Pramod Dhembare

As per the report published by Deloitte, pharmaceutical companies are allocating 40-85 % of PV budgets on case processing, and case volumes are increasing at a rate of 10-15 per cent per year.

Why smart case processing in pharmacovigilance needs automation more than ever before

by Dr. Pramod Dhembare |Nov 18, 2021

Strategies of standardisation and automation of PV processes designed with combined skillsets of pharmacovigilance domain experts, data scientists and IT engineers have the capability to enhance the c...